Table 3.
Self-management support
| Items* | T0 (n = 109) mean (SD) |
Tx1 (n = 87) mean (SD) |
Tx2 (n = 87) mean (SD) |
Wilcoxon matched pair test, p-valuea | Test-retest reliability: Spearman rho | |
|---|---|---|---|---|---|---|
| r | p-valueb | |||||
| Handout of non individualized information sheets dealing with the disease on a daily basis and in difficult conditions | 3.23 (0.94) | 3.25 (0.95) | 3.21 (0.89) | 0.66 | 0.51 | < 0.01 |
| Handout of an individualized treatment plan with information on how to deal with the disease on an every day basis and in difficult conditions | 2.91 (1.12) | 3.09 (1.10) | 2.96 (1.04) | 0.26 | 0.54 | < 0.01 |
| Discussion of care/therapy options with the patients to achieve an agreed therapy concept | 1.69 (0.63) | 1.71 (0.65) | 1.79 (0.67) | 0.23 | 0.56 | < 0.01 |
| Assessment of drug history including OTC and prescription drugs from other physicians | 1.49 (0.67) | 1.49 (0.70) | 1.64 (0.67) | 0.02 | 0.63 | < 0.01 |
| Usage of specific instruments to calculate individual risks, e.g., for coronary heart disease | 3.62 (1.07) | 3.67 (1.04) | 3.67 (1.04) | 0.89 | 0.62 | < 0.01 |
| Handout of a patient-booklets for documentation, e.g., of blood glucose or pain levels | 2.26 (0.85) | 2.38 (0.85) | 2.35 (0.91) | 0.78 | 0.65 | < 0.01 |
| Handout of guideline information | 3.19 (1.02) | 3.24 (1.04) | 3.11 (0.90) | 0.16 | 0.67 | < 0.01 |
| Involvement of patient family members, if desired | 1.75 (0.77) | 1.80 (0.80) | 1.86 (0.80) | 0.48 | 0.50 | < 0.01 |
* Five-point scale ranging from 1 "always" to 5 "never"
a Statistical significance of differences: P ≤ 0.05; b Statistical significance of differences: P ≤ 0.01